A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol. (Trials, 2013)

(untitled) - Mullen, M; Flather, MD; Jin, X; Newman, W; Erdem, G; Gaze, D; Valencia, O; Banya, W; Foley, C; Child, A